• In late June 2026, Morningstar, Inc. was removed from the Russell 1000 Defensive, Growth-Defensive, and Value-Defensive indexes, coinciding with its continued dividend payments and upcoming second-quarter 2026 results release.
• At the same time, Morningstar advanced its AI-integrated investment intelligence offering through new Microsoft 365 Copilot integrations and expanded its indexing capabilities via a collaboration with Houlihan Lokey on daily CLO valuation benchmarks.
• Against this backdrop, we’ll explore how Morningstar’s removal from key Russell 1000 defensive indexes shapes its broader investment narrative and positioning.

Find 41 companies with promising cash flow potential yet trading below their fair value.

What Is Morningstar's Investment Narrative?

For someone considering Morningstar, the core belief is that its independent data, research, and software will keep mattering to institutions and advisors even as tools change. The recent removal from multiple Russell 1000 defensive indexes may bring some short term technical selling pressure, especially after a tough 12‑month share price run, but it does not obviously alter the fundamentals that drive earnings: adoption of its data platforms, retention of asset manager clients, and disciplined capital allocation through dividends and buybacks. If anything, the Microsoft 365 Copilot integrations and the Houlihan Lokey CLO index partnership speak to Morningstar leaning harder into workflow-embedded analytics and specialized benchmarks, which are important current catalysts. The bigger near term risks still look operational: high leverage, slower forecast growth, and recent insider selling.

Morningstar's shares are on the way up, but they could be overextended by 21%. Uncover the fair value now.

Exploring Other Perspectives

Seven fair value estimates from the Simply Wall St Community stretch from US$133.69 to US$329.06, reflecting very different expectations. Against that spread, the recent index removals and Morningstar’s high debt levels are key context that could influence how you view both upside potential and balance sheet risk over time, so it is worth weighing several viewpoints before deciding how this fits in a portfolio.

Explore 7 other fair value estimates on Morningstar - why the stock might be worth 17% less than the current price!

Reach Your Own Conclusion

Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Morningstar research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Morningstar research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Morningstar's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.
• Rare earth metals are the new gold rush. Find out which 31 stocks are leading the charge.
• AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.